miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
Authors:
Open Access
- 1 October 2018
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 4735-4745
Abstract
Objective: microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC) remains obscure. The objective of this study was to investigate the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. Materials and methods: All the experimental methods used were as follows: microarray analysis, cell culture, transient, and stable gene transfection; real-time fluorescence PCR; Western blot; flow cytometry for cell cycle analysis; in vitro proliferation assay; in vitro wound healing experiment; in vivo xenograft model in nude mice; and dual luciferase reporter assay. All statistical analyses were carried out using GraphPad Prism 7 software. Statistical significance was analyzed by Student’s t-test or one-way ANOVA. P Results: In this study, we observed that miR-216a-5p is downregulated in SCLC cell lines compared to that in the normal human bronchial epithelial cell line 16-HBE. In vitro and in vivo experiments demonstrate that upregulation of miR-216a-5p significantly decreased cell growth and migration and its downregulation increased SCLC cell proliferation and migration and influenced the cell cycle. Using bioinformatics analyses, we predicted that the important antiapoptotic gene Bcl-2 is targeted by miR-216a-5p, and we identified a functional miR-216a-5p binding site in the 3′-UTR of Bcl-2 using luciferase reporter assay. Furthermore, we determined that suppression of miR-216a-5p modulated the expression of Bcl-2, Bax, and Bad proteins (Bcl-2 family proteins), while Bcl-2 knockdown abrogated the effect of miR-216a-5p downregulation on cell proliferation, cell migration, and the cell cycle. Conclusion: Taken together, these findings suggest that miR-216a-5p regulates SCLC biology via Bcl-2 family proteins. Therefore, our study highlights the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis.Keywords
This publication has 25 references indexed in Scilit:
- Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical applicationCellular Oncology, 2016
- Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.2015
- miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathwayCell Death & Differentiation, 2015
- Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation statusDiagnostic Pathology, 2015
- Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.2015
- [Expression of miR-216a in pancreatic cancer and its clinical significance].2012
- Polymorphisms in miRNA binding site: new insight into small cell lung cancer susceptibilityActa Pharmacologica Sinica, 2011
- Genetic Variation in an miRNA-1827 Binding Site in MYCL1 Alters Susceptibility to Small-Cell Lung CancerCancer Research, 2011
- MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCsJournal of Experimental & Clinical Cancer Research, 2010
- Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysisEuropean Journal of Cancer, 2010